Who should be treating adolescents and young adults with acute lymphoblastic leukaemia?
- 1 December 2003
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 39 (18) , 2579-2583
- https://doi.org/10.1016/j.ejca.2003.09.005
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 TrialsJournal of Clinical Oncology, 2003
- Differences in Outcome in Adolescents With Acute Lymphoblastic Leukemia: A Consequence of Better Regimens? Better Doctors? Both?Journal of Clinical Oncology, 2003
- Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995Leukemia, 2000
- Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995Leukemia, 2000
- Outcome of Treatment in Children with Philadelphia Chromosome–Positive Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 2000
- Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1998
- Intensive chemotherapy for Philadelphia-chromosome-positive acute lymphoblastic leukaemiaThe Lancet, 1994
- Acute Lymphoblastic Leukemia -- Progress in Children, Less in AdultsNew England Journal of Medicine, 1993
- Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemiaCancer Genetics and Cytogenetics, 1989
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989